Your Best Stock
Stocks Biotechnology REGN

Regeneron Pharmaceuticals REGN

US equityMarket cap rank #199BiotechnologyInfectious Disease
$791.33
−$10.50 (-1.31%)
Market open · Sep 24, 1:10 pm ET
After hours $801.82 0.00%
Open$801.59
Prev close$801.82
Day range$789.41 – $807.21
Volume246.9K
Market cap$81.47B
P/E (TTM)19.6
Dividend yield0.46%

Valuation

Multiples measured against the stock's own five-year history

Price / earnings19.4x
CheapRich

Above its usual level · 63rd percentile, 5-year average 18.1x

#1514 of 2974 stocks by PE (1 = cheapest)

Price / book2.5x
CheapRich

Below its usual level · 24th percentile, 5-year average 3.3x

#3327 of 5298 stocks by PB (1 = cheapest)

Price / sales5.2x
CheapRich

Below its usual level · 38th percentile, 5-year average 5.9x

#3880 of 5139 stocks by PS (1 = cheapest)

P/E over five years

6x15x25x34xSep '21Mar '24Sep '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$784.00
Price vs. fair value+0.9%Close to the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyMedium
MultipleCurrent5y averagePercentile vs. own historyIndustry rank
PB 2.55 3.28 24% (cheaper than usual) #3327 of 5298 (1 = cheapest)
PE 19.42 18.05 63% (pricier than usual) #1514 of 2974 (1 = cheapest)
PS 5.20 5.90 38% (cheaper than usual) #3880 of 5139 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies.

Morningstar view

Star rating★★★
Fair value estimate$784.00
Economic moatNarrow
UncertaintyMedium
Scroll to Top